Answers are grounded in this paper and cite their sources.
Background: Colorectal cancer (CRC) represents a rapidly escalating public health challenge in the Kingdom of Saudi Arabia (KSA), where it is the second most common cancer overall and the leading cancer among men.(1,2) Methods: A Systematic review of current evidence for colorectal cancer in Saudi Arabia, its financial impact, and the human resources required to support care of such burden. A comprehensive literature search was conducted across PubMed/MEDLINE, Embase, Scopus, Web of Science, and Google Scholar, as well as gray literature sources, including Saudi National Cancer Registry reports and documents from the Saudi Ministry of Health. The search identified 27 records from database searching and 21 records from the registry and other sources. After the removal of 8 duplicates, 40 records were screened at the title and abstract level. Full texts of CRC articles were assessed for eligibility, of which 10 were excluded (non-Saudi populations, insufficient CRC-specific data, or non-original research), leaving 30 studies included in the final qualitative synthesis. A PRISMA-style flow was used to summarize the study selection process. Results: In 2020, the incidence and mortality rate of CRC in Saudi Arabia were 14.6% and 1.48% among all cancers, respectively [1]. National guidelines in Saudi Arabia recommend CRC screening for all individuals above 45 years using colonoscopy, flexible sigmoidoscopy, or fecal occult blood test. The incidence of cancer increased (1990-2016) approximately 10-fold for colon Cancer [2], A dangerous combination of genetic vulnerability and modern lifestyle pressures fuels this epidemic. Approximately 11.6% of young Saudi CRC patients have confirmed Lynch Syndrome(3). And 83% of all Saudi CRC patients carry the GSTM1 null genotype, this genetic trait leaves them highly sensitive to environmental carcinogens [4]. These genetic risks collide with modifiable factors, including sedentary habits and poor knowledge of high-fiber diets [5,2,4], leading to metabolic weaknesses like widespread Vitamin D deficiency [6]. The high overall one-, three-, and five-year survival rates were 83, 65, and 52.0% [7]. is fundamentally driven by failures in early detection. Screening rates are extremely low [8,9] primarily because physicians fail to recommend testing [8,10] and the public wrongly believes screening is unnecessary unless they feel sick [9,10,11]. Conclusion: To control Colorectal cancer demands immediate risk-stratification, genetic testing for all early-onset cases, and aggressive, physician-led efforts to increase public engagement with non-invasive screening options. The increasing incidence of CRC in Saudi Arabia, along with rising treatment costs, underscores the necessity for early detection and efficient healthcare resource allocation. Managing the projected increase in CRC cases over the next five years requires a strategic assessment of workforce needs, including ensuring sufficient numbers of oncologists, nurses, and allied health professionals, alongside effective training and recruitment strategies.
No takes yet. Share an insight, caveat, or question.
Kofi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: